학술논문
Tumour growth rate improves tumour assessment and first-line systemic treatment decision-making for immunotherapy in patients with liver metastatic uveal melanoma.
Document Type
Journal Article
Author
Source
Subject
*MELANOMA
*LIVER
*UVEA cancer
*RETROSPECTIVE studies
*SECONDARY primary cancer
*IMMUNOTHERAPY
*
*
*
*
*
Language
ISSN
0007-0920
Abstract